MA32211B1 - Traitement de troubles oculaires - Google Patents
Traitement de troubles oculairesInfo
- Publication number
- MA32211B1 MA32211B1 MA33226A MA33226A MA32211B1 MA 32211 B1 MA32211 B1 MA 32211B1 MA 33226 A MA33226 A MA 33226A MA 33226 A MA33226 A MA 33226A MA 32211 B1 MA32211 B1 MA 32211B1
- Authority
- MA
- Morocco
- Prior art keywords
- treatment
- eye disorders
- diabetic
- emphysema
- thanks
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3507308P | 2008-03-10 | 2008-03-10 | |
| PCT/US2009/036119 WO2009114373A1 (en) | 2008-03-10 | 2009-03-05 | Treatment for ocular-related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA32211B1 true MA32211B1 (fr) | 2011-04-01 |
Family
ID=40583469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA33226A MA32211B1 (fr) | 2008-03-10 | 2010-10-06 | Traitement de troubles oculaires |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP2285378A1 (zh) |
| JP (1) | JP2011513488A (zh) |
| KR (1) | KR20110009084A (zh) |
| CN (1) | CN101965188A (zh) |
| AR (1) | AR070975A1 (zh) |
| AU (1) | AU2009223501A1 (zh) |
| BR (1) | BRPI0909659A2 (zh) |
| CA (1) | CA2717991A1 (zh) |
| CL (1) | CL2009000551A1 (zh) |
| CO (1) | CO6290691A2 (zh) |
| CR (1) | CR11644A (zh) |
| DO (1) | DOP2010000266A (zh) |
| IL (1) | IL207906A0 (zh) |
| MA (1) | MA32211B1 (zh) |
| MX (1) | MX2010008308A (zh) |
| NI (1) | NI201000131A (zh) |
| NZ (1) | NZ587906A (zh) |
| RU (1) | RU2010141560A (zh) |
| SV (1) | SV2010003658A (zh) |
| TW (1) | TW200950784A (zh) |
| WO (1) | WO2009114373A1 (zh) |
| ZA (1) | ZA201005337B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR074776A1 (es) | 2008-12-18 | 2011-02-09 | Sanofi Aventis | Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente |
| EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
| EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1263759B1 (en) * | 1999-12-24 | 2010-09-08 | Aventis Pharma Limited | Azaindoles |
| CA2400923A1 (en) * | 2000-02-25 | 2001-08-30 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| EP1928456B1 (en) * | 2005-09-30 | 2015-04-22 | Miikana Therapeutics, Inc. | Substituted pyrazole compounds |
| CL2007002617A1 (es) * | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
-
2009
- 2009-03-05 EP EP09718970A patent/EP2285378A1/en not_active Withdrawn
- 2009-03-05 CA CA2717991A patent/CA2717991A1/en not_active Abandoned
- 2009-03-05 NZ NZ587906A patent/NZ587906A/en not_active IP Right Cessation
- 2009-03-05 KR KR1020107019973A patent/KR20110009084A/ko not_active Application Discontinuation
- 2009-03-05 AU AU2009223501A patent/AU2009223501A1/en not_active Abandoned
- 2009-03-05 MX MX2010008308A patent/MX2010008308A/es not_active Application Discontinuation
- 2009-03-05 RU RU2010141560/15A patent/RU2010141560A/ru unknown
- 2009-03-05 CN CN2009801075816A patent/CN101965188A/zh active Pending
- 2009-03-05 JP JP2010550758A patent/JP2011513488A/ja not_active Withdrawn
- 2009-03-05 WO PCT/US2009/036119 patent/WO2009114373A1/en active Application Filing
- 2009-03-05 BR BRPI0909659A patent/BRPI0909659A2/pt not_active IP Right Cessation
- 2009-03-09 AR ARP090100835A patent/AR070975A1/es not_active Application Discontinuation
- 2009-03-09 CL CL2009000551A patent/CL2009000551A1/es unknown
- 2009-03-09 TW TW098107567A patent/TW200950784A/zh unknown
-
2010
- 2010-07-27 ZA ZA2010/05337A patent/ZA201005337B/en unknown
- 2010-07-29 NI NI201000131A patent/NI201000131A/es unknown
- 2010-08-24 CR CR11644A patent/CR11644A/es not_active Application Discontinuation
- 2010-08-31 IL IL207906A patent/IL207906A0/en unknown
- 2010-09-01 CO CO10108103A patent/CO6290691A2/es not_active Application Discontinuation
- 2010-09-02 DO DO2010000266A patent/DOP2010000266A/es unknown
- 2010-09-07 SV SV2010003658A patent/SV2010003658A/es unknown
- 2010-10-06 MA MA33226A patent/MA32211B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ587906A (en) | 2011-12-22 |
| WO2009114373A1 (en) | 2009-09-17 |
| MX2010008308A (es) | 2010-08-11 |
| AR070975A1 (es) | 2010-05-19 |
| CO6290691A2 (es) | 2011-06-20 |
| ZA201005337B (en) | 2011-04-28 |
| NI201000131A (es) | 2011-09-29 |
| JP2011513488A (ja) | 2011-04-28 |
| AU2009223501A1 (en) | 2009-09-17 |
| CL2009000551A1 (es) | 2009-08-21 |
| CN101965188A (zh) | 2011-02-02 |
| CA2717991A1 (en) | 2009-09-17 |
| SV2010003658A (es) | 2011-01-31 |
| KR20110009084A (ko) | 2011-01-27 |
| RU2010141560A (ru) | 2012-04-20 |
| IL207906A0 (en) | 2010-12-30 |
| TW200950784A (en) | 2009-12-16 |
| CR11644A (es) | 2010-11-22 |
| EP2285378A1 (en) | 2011-02-23 |
| BRPI0909659A2 (pt) | 2015-09-22 |
| DOP2010000266A (es) | 2010-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20146072B (en) | New compounds | |
| MA37572A1 (fr) | Compositions pesticides et procédés correspondants | |
| MY170713A (en) | Treatment protocol of diabetes type 2 | |
| MA35920B1 (fr) | Composés destinés au traitement de l'amyotrophie spinale | |
| UA113051C2 (xx) | Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів | |
| EA201590053A1 (ru) | Модуляторы пути системы комплемента и их применение | |
| EA201001639A1 (ru) | Композиции и способы их получения и применения | |
| TR201902788T4 (tr) | Nörodejeneratif hastalıkların tedavisinde kullanışlı 1-arilkarbonil-4-oksi-piperidin bileşikleri. | |
| EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
| CU24083B1 (es) | Derivados de oxazina útiles como inhibidores de bace para el tratamiento de trastornos neurológicos | |
| ECSP066373A (es) | Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
| MX2015007916A (es) | Peri-carbinoles. | |
| EA201200176A1 (ru) | Производные оксазина и их применение для лечения неврологических нарушений | |
| EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
| PH12014502624B1 (en) | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases | |
| MX2011008395A (es) | Nuevas amino carboxamidas azaheterociclicas. | |
| SG178963A1 (en) | Compounds as tyrosine kinase modulators | |
| MA32505B1 (fr) | 5-alcynyl-pyrimidines | |
| CR20130264A (es) | Compuestos pirimidinona para uso en el tratamiento de enfermedades o condiciones mediadas por lp-pla2 | |
| EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
| EA201200570A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| DK2257275T3 (da) | Ketorolactromethaminsammensætninger til behandling eller forebyggelse af øjensmerte | |
| EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
| ATE554076T1 (de) | Sulfoximinsubstituierte chinazolinderivate als immunmodulatoren, ihre herstellung und ihre verwendung als medikamente | |
| GEP20156315B (en) | Oxazoline and isoxazoline derivatives as crac modulators |